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cells through activating the MEK1/2-ERK1/2-NF-κB
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Background: Lipoteichoic acid (LTA), a gram-positive bacterial outer membrane component, can cause septic
shock. Our previous studies showed that the gram-negative endotoxin, lipopolysaccharide (LPS), could induce
surfactant protein-A (SP-A) production in human alveolar epithelial (A549) cells.
Objectives: In this study, we further evaluated the effect of LTA on SP-A biosynthesis and its possible
signal-transducing mechanisms.
Methods: A549 cells were exposed to LTA. Levels of SP-A, nuclear factor (NF)-κB, extracellular signal-regulated
kinase 1/2 (ERK1/2), and mitogen-activated/extracellular signal-regulated kinase kinase (MEK)1 were determined.
Results: Exposure of A549 cells to 10, 30, and 50 μg/ml LTA for 24 h did not affect cell viability. Meanwhile, when
exposed to 30 μg/ml LTA for 1, 6, and 24 h, the biosynthesis of SP-A mRNA and protein in A549 cells significantly
increased. As to the mechanism, LTA enhanced cytosolic and nuclear NF-κB levels in time-dependent manners.
Pretreatment with BAY 11–7082, an inhibitor of NF-κB activation, significantly inhibited LTA-induced SP-A mRNA
expression. Sequentially, LTA time-dependently augmented phosphorylation of ERK1/2. In addition, levels of
phosphorylated MEK1 were augmented following treatment with LTA.
Conclusions: Therefore, this study showed that LTA can increase SP-A synthesis in human alveolar type II epithelial
cells through sequentially activating the MEK1-ERK1/2-NF-κB-dependent pathway.
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Sepsis can lead to multiorgan failure and death and
appears to be triggered by bacterial products, such as
lipopolysaccharide (LPS) from gram-negative bacteria
and lipoteichoic acid (LTA) from gram-positive ones [1-
3]. Infection of the respiratory tract caused by gram-
positive bacteria and pneumonia combined with acute
lung injury (ALI) are usually the leading causes of* Correspondence: rmchen@tmu.edu.tw
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reproduction in any medium, provided the ormortality by sepsis [4]. In the past few decades, the inci-
dences of sepsis and septic shock have been increasing
[5]. Although endotoxin-activated events are clearly im-
portant in gram-negative infection, gram-positive bac-
teria also have crucial roles, but less is known about
host responses to them [6]. The increasing prevalence of
sepsis from gram-positive bacterial pathogens necessi-
tates a reevaluation of the basic assumptions about the
molecular pathogenesis of ALI.
Alveolar epithelial type II cells contribute to the main-
tenance of mucosal integrity by modulating the produc-
tion of surfactants [7]. Pulmonary surfactants play
important roles in protecting the lung during endotoxin-
induced injury and infection [8,9]. Surfactant proteinThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tein. Levels of SP-A in bronchiolar lavage fluid are
modulated in gram-negative or -positive bacteria-caused
lung diseases, including severe pneumonia, acute re-
spiratory distress syndrome, and cardiogenic lung edema
[10]. Thus, altering lung SP-A levels can be an effective
indicator for pulmonary infection and inflammation.
Our previous study showed that LPS selectively induced
sp-a gene expression in human alveolar epithelial A549
cells [11].
LTA, an outer membrane component of gram-positive
bacteria, was shown to be one of the critical factors partici-
pating in the pathogenesis of sepsis [12,13]. LTA can stimu-
late inflammatory responses in the lung [14,15]. Therefore,
understanding the mechanisms that regulate LTA-mediated
cell activation is crucial for diagnosis, treatment, or progno-
sis of lung inflammatory diseases. In response to stimuli,
LTA can activate macrophages to produce massive amounts
of inflammatory factors that exhibit systemic effects in the
general circulation [16]. LTA can induce the secretion of
various cytokines such as interleukin (IL)-1β, IL-6, and
tumor necrosis factor (TNF)-α [17]. These data suggest that
LTA can selectively modify gene transcription of various
cell types and sequentially augment and possibly initiate tis-
sue inflammation.
Mitogen-activated protein kinases (MAPKs) are
serine/threonine kinases. The first MAPK isoforms to be
cloned and characterized were the extracellular signal-
regulated kinase 1 and 2 (ERK 1/2) [18,19]. ERK 1/2 are
well documented to be activated by a family of dual-
specificity kinases known as the mitogen-activated/ERK
kinases (MEKs) [16,20]. A previous study demonstrated
that LTA can selectively activate the ERK pathway in the
cornea [21]. Our previous study showed that LTA
induced TNF-α and IL-6 expressions by means of stimu-
lating phosphorylation of ERK1/2 in macrophages [16].
In addition, LTA also triggered translocation of nuclear
factor (NF)-κB from the cytoplasm to nuclei and its
transactivation activity. Meanwhile, the mechanisms re-
sponsible for LTA-induced sp-a gene expression in al-
veolar epithelial cells are still unknown. In this study, we
attempted to evaluate the effects of LTA on SP-1 synthe-
sis in human alveolar type II epithelial cells and its pos-
sible mechanisms.
Materials and methods
Cell culture and drug treatment
A human lung carcinoma type II epithelial cell line
(A549) was cultured following a previous method [3].
A549 cells were grown in Dulbecco's modified Eagle's
medium (DMEM)/Ham’s F12 culture medium (Sigma,
St. Louis, MO, USA), supplemented with 10% (v/v) heat-
inactivated fetal calf serum, 100 U/ml penicillin G, 100
μg/ml streptomycin, and 2 mM l-glutamine. A549 cellswere seeded in 75-cm2 culture flasks at 37 °C in a hu-
midified atmosphere of 5% CO2. Cells were grown to
confluence before drug treatment. LTA purchased from
Sigma was dissolved in phosphate-buffered saline (PBS)
(0.14 M NaCl, 2.6 mM KCl, 8 mM Na2HPO4, and 1.5
mM KH2PO4). BAY 11–7082, an inhibitor of NF-κB ac-
tivation, was also purchased from Sigma.
Assay of cell viability
Cell viability was determined using a colorimetric 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
as previously described [22]. Briefly, A549 cells (104
cells/well) were seeded in 96-well tissue culture plates
overnight. After drug treatment, macrophages were
cultured in new medium containing 0.5 mg/mL 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide for
a further 3 h. The blue formazan products in the macro-
phages were dissolved in dimethyl sulfoxide and spectro-
photometrically measured at a wavelength of 550 nm.
Immunoblotting analyses of SP-A, NF-κB, and
phosphorylated and non-phosphorylated ERK1/2 and
MEK1
Protein levels were immunodetected according to a pre-
viously described method [11]. After drug treatment, cell
lysates were prepared in ice-cold radioimmunoprecipita-
tion assay buffer (25 mM Tris–HCl (pH 7.2), 0.1% so-
dium dodecylsulfate (SDS), 1% Triton X-100, 1% sodium
deoxycholate, 0.15 M NaCl, and 1 mM EDTA). Protein
concentrations were quantified using a bicinchonic acid
protein assay kit (Pierce, Rockford, IL, USA). Proteins
(50 μg/well) were subjected to sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to nitrocellulose membranes. Immunodetec-
tion of SP-A and NF-κB was carried out using rabbit
polyclonal antibodies against human SP-A and NF-κB
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cel-
lular β-actin protein was immunodetected using a
mouse monoclonal antibody (mAb) against mouse β-
actin (Sigma) as the internal standard. These protein
bands were quantified using a digital imaging system
(UVtec, Cambridge, UK). Phosphorylated ERK1/2 and
MEK1 were immunodetected using a rabbit polyclonal
antibody against phosphorylated residues of ERK1/2 and
MEK1 (Cell Signaling, Danvers, MA, USA). Nonpho-
sphorylated ERK2 and MEK1 were immunodetected
as the internal controls (Cell Signaling). Intensities of
the immunoreactive bands were determined using a
digital imaging system (Wallac Victor 1420, PerkinElmer,
Melbourne, Australia).
Extraction of nuclear proteins and immunodetection
Amounts of nuclear transcription factors were quantified
following a previously described method [20]. After drug
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Figure 1 Effects of lipoteichoic acid (LTA) on the production of
surfactant protein (SP)-A. A549 cells were exposed to 30 μg/ml
LTA for 1, 6, and 24 h (A). Cellular proteins were prepared for the
immunoblotting analyses. Amounts of SP-A were immunodetected
(A, top pane). β-Actin was detected as the internal standard (bottom
panel). These protein bands were quantified and analyzed (B). Each
value represents the mean ± SEM for n = 6. An asterisk (*) indicates
that a value significantly differed from the control groups, p < 0.05.
AU, arbitrary unit.
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pared. Protein concentrations were quantified by a
bicinchonic acid protein assay kit (Pierce, Rockford, IL,
USA). Nuclear proteins (50 μg/well) were subjected to
SDS-PAGE and transferred to nitrocellulose membranes.
After blocking, NF-κB was immunodetected using a
rabbit polyclonal antibody against mouse NF-κB p65
(Santa Cruz Biotechnology). A proliferating cell nuclear
antigen (PCNA) was detected using a mouse mAb against
the rat PCNA protein (Santa Cruz Biotechnology) as the
internal standard. Intensities of the immunoreactive bands
were determined using a digital imaging system (Wallac
Victor 1420, PerkinElmer).
Real-time polymerase chain reaction (PCR) assays
Messenger (m)RNA from A549 cells exposed to LTA were
prepared for real-time PCR analyses of SP-A mRNA and
β-actin mRNA. Oligonucleotides for the PCR analyses of
SP-A mRNA and β-actin mRNA were designed and
synthesized by Clontech Laboratories (Palo Alto, CA,
USA). The oligonucleotide sequences of the upstream and
downstream primers for these mRNA analyses were re-
spectively 5'-TGA AAGGGAGTTCTAGCATCTCA
CAGA-3' and 5'-ACATATGCCTATGTAGGCCTGACT
GAG-3' for SP-A mRNA, and 5'- GTCTACATGTCTC
GATCCCACTTA A -3' and 5'-GGTCTTTCTCTCTCAT
CGCGCTC-5' for β-actin mRNA. A quantitative PCR
analysis was carried out using iQSYBR Green Supermix
(Bio-Rad, Hercules, CA, USA) and the MyiQ Single-Color
Real-Time PCR Detection System (Bio-Rad) as described
previously [11].
Statistical analysis
Statistical differences were considered significant when
the p value of Duncan’s multiple-range test was <0.05.
Statistical analysis between groups over time was carried
out by a two-way analysis of variance (ANOVA).
Results
Toxicity of LTA to A549 cells
Cell morphology and viability were assayed to evaluate
the toxicity of LTA to human alveolar epithelial A549
cells. Exposure of A549 cells to 10, 30, and 50 μg/ml
LTA for 24 h did not affect cell viability (data not
shown). When exposed to 30 μg/ml LTA for 1, 6, and 24
h, the viability of A549 cells was not influenced. Expos-
ure of A549 cells to 30 μg/ml LTA for 1, 6, and 24 h did
not alter cell morphology (data not shown).
LTA-induced enhancement of SP-A biosynthesis in A549
cells
The effects of LTA on SP-A levels in A549 cells were evalu-
ated by an immunoblotting analysis (Figure 1). In untreated
A549 cells, low levels of SP-A were immunodetected(Figure 1A, top panel, lane 1). After exposure to 30 μg/ml
LTA for 1 h, levels of SP-A were found to be augmented
(lane 2). When treated for 6 and 24 h, LTA obviously
increased amounts of SP-A in A549 cells. β-Actin was
immunodetected (Figure 1A, bottom panel). These immu-
norelated protein bands were quantified and analyzed
(Figure 1B). Exposure of A549 cells to 30 μg/ml LTA for 1,
6, and 24 h respectively caused significant 176%, 230%, and
270% increases in SP-A levels.LTA-induced SP-A mRNA expression in A549 cells
Induction of SP-A mRNA expression by LTA was quan-
tified using a real-time PCR analysis (Figure 2). After
exposure to LTA for 1 h, the levels of SP-A mRNA in
A549 cells were increased by 2.1-fold. Exposure of A549
cells to LTA for 6 and 24 h caused 2.8- and 3.7-fold
increases in the levels of SP-A mRNA, respectively
(Figure 2). Pretreatment of A549 cells with BAY 11–
7082, an inhibitor of NF-κB activation, for 1 h did not
change SP-A mRNA expression (data not shown).
However, BAY 11–7082 significantly inhibited LTA-
induced SP-A mRNA production by 70% (Figure 2).
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Figure 2 Effects of lipoteichoic acid (LTA) on induction of
surfactant protein (SP)-A mRNA. A549 cells were exposed to 30
μg/ml LTA for 1, 6, and 24 h. In addition, A549 cells were pretreated
with BAY 11–7082 (BAY), an inhibitor of NF-κB activation, for 1 h
and then exposed to LTA for another 24 h. mRNA was prepared for
real-time PCR analyses of SP-A mRNA and β-actin mRNA. Each value
represents the mean ± SEM for n = 3. Symbols * and # indicate that
the value significantly (p < 0.05) differed from the respective control
and LTA-treated group, respectively.
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Figure 3 Effects of lipoteichoic acid (LTA) on the expression of
the transcription factor, nuclear factor (NF)-κB. A549 cells were
exposed to 30 μg/ml LTA for 1, 6, and 24 h. Levels of cytosolic NF-
κB p65 (cNF-κB) were immunodetected (A, top panel). β-Actin was
detected as the internal standard (bottom panel). These protein
bands were quantified and analyzed (B). Each value represents the
mean ± SEM for n = 6. An asterisk (*) indicates that a value
significantly differed from the control groups, p < 0.05. AU, arbitrary
unit.
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by LTA
Mechanisms of LTA-induced SP-A augmentation were
evaluated by analyses of NF-κB expression and trans-
location (Figures 3 and 4). Exposure of A549 cells to
LTA for 1 h enhanced levels of cytosolic NF-κB
(Figure 3A, top panel, lane 1). After treatment for 6 and
24 h, the expression of cytosolic NF-κB was obviously
augmented (lanes 3 and 4). β-Actin was immunode-
tected (Figure 3A, bottom panel). These immunorelated
protein bands were quantified and analyzed (Figure 3B).
Exposure of A549 cells to LTA for 1, 6, and 24 h signifi-
cantly increased NF-κB production by 181%, 200%, and
230%, respectively.
Treatment of A549 cells with LTA for 1 h increased
levels of nuclear NF-κB (Figure 4A, top panel, lane 2).
When exposed for 6 and 24 h, translocation of NF-κB
from the cytoplasm to nuclei notably increased (lanes 3
and 4). Amounts of PCNA in A549 cells were immuno-
detected (Figure 4A, bottom panel). These immunore-
lated protein bands were quantified and analyzed
(Figure 4B). Exposure of A549 cells to LTA for 1, 6, and
24 h respectively caused significant 176%, 340%, 530%
enhancements in levels of nuclear NF-κB.
LTA-enhanced phosphorylation of ERK1/2
The reason why LTA improved NF-κB activation was
further investigated by assaying ERK1/2 phosphorylation
(Figure 5). Treatment of A549 cells with LTA for 1 h
increased the amounts of phosphorylated ERK1/2(Figure 5A, top panel, lane 2). Levels of phosphorylated
ERK1/2 in A549 cells were obviously raised after expos-
ure to LTA for 6 and 24 h (lanes 3 and 4). Amounts of
β-actin in A549 cells were immunodetected (Figure 5A,
bottom panel). These immunorelated protein bands were
quantified and analyzed (Figure 5B). Exposure of A549
cells to LTA for 1, 6, and 24 h significantly increased
ERK1 phosphorylation by 259%, 170%, and 334%, re-
spectively. In comparison, levels of phosphorylated
ERK2 were respectively augmented by 8.2-, 6.4-, and
7.8-fold following LTA administration for 1, 6, and 24 h
(Figure 5B).
LTA-induced activation of MEK1
Phosphorylation of MEK1 was assayed to determine the
mechanism of LTA-induced ERK1/2 activation (Figure 6).
Low levels of phosphorylated MEK1 were detected in un-
treated A549 cells (Figure 6A, top panel, lane 1). However,
exposure of A549 cells to LTA for 1 h stimulated MEK1
phosphorylation (lane 2). After exposure for 6 and 24 h,
the amounts of phosphorylated MEK1 had obviously
increased (lanes 3 and 4). β-actin in A549 cells was immu-
nodetected (Figure 6A, bottom panel). These immunore-
lated protein bands were quantified and analyzed
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Figure 4 Effects of lipoteichoic acid (LTA) on translocation of
the transcription factor, nuclear factor (NF)-κB, from the
cytoplasm to nuclei. A549 cells were exposed to 30 μg/ml LTA for
1, 6, and 24 h. Amounts of nuclear NF-κB p65 (nNF-κB) were
immunodetected (A, top panel). Proliferating cell nuclear antigen
(PCNA) was detected as the internal standard (bottom panel). These
protein bands were quantified and analyzed (B). Each value
represents the mean ± SEM for n = 6. An asterisk (*) indicates that a
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Figure 5 Effects of lipoteichoic acid (LTA) on the
phosphorylation of extracellular signal-regulated kinase
(ERK)1/2. A549 cells were exposed to 30 μg/ml LTA for 1, 6, and
24 h. Phosphorylated ERK1/2 (p-ERK1/2) were immunodetected
(A, top panel). ERK2 was detected as the internal standard (bottom
panel). These immunorelated protein bands were quantified and
analyzed (B). Each value represents the mean ± SEM for n = 6.
An asterisk (*) indicates that a value significantly differed from the
control group, p < 0.05. AU, arbitrary unit.
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and 24 h respectively caused significant 82%, 330%, and
370% increases in levels of phosphorylated MEK1.
Discussion
LTA represents a class of amphiphilic molecules
anchored to the outer face of the cytoplasmic membrane
in gram-positive bacteria and is commonly released dur-
ing cell growth, especially under antibiotic therapy [1,2].
It can cause cytokine induction in mononuclear phago-
cytes [17]. In previous studies, LTA concentrations of
0.2~50 μg/ml were detected and stimulated activity
of polymononuclear leucocyte functions and release of
TNF-α in peripheral blood mononuclear cells [23,24].
Meanwhile, LTA levels at the infectious site can reach a
high level of 26,694 ng/mL [25]. The concentration of
LTA used in this study was < 50 μg/ml. Therefore, our
results show that LTA at clinically relevant concentra-
tions can activate alveolar type II epithelial cells by
stimulating production of surfactants.
During bacterial infection, endotoxins, including LTA
and LPS, increase capillary permeability and enhance
expressions of cellular adhesion molecules, proinflam-
matory cytokines, and chemokines [1,15]. Theseendotoxins can lead to most of the clinical manifesta-
tions of bacterial infection and are associated with ALI
[4,5]. In addition, LTA can trigger lung inflammation
and causes neutrophil influx into the lungs [15,26]. This
study showed that in response to LTA stimulation, levels
of SP-A mRNA and protein in alveolar A549 cells were
time-dependently augmented. SP-A contributes to the
pulmonary host defense [10,16,27]. A previous study
reported that when sp-a gene expression was knocked-
out, susceptibility of the lungs to pathogenic infection
was simultaneously raised [28]. Our previous study also
showed that LPS-mediated toll-like receptor (TLR) 2 sig-
naling in human alveolar epithelial cells might increase
SP-A biosynthesis and subsequently lead to an inflam-
matory response in the lungs [3]. As a result, SP-A could
be an effective biomarker for detecting pulmonary infec-
tion by gram-negative or -positive bacteria.
This study showed that LTA increased the expression
of NF-κB and its translocation from the cytoplasm to
nuclei. NF-κB is a typical transcription factor in response
to stimulation by LTA [16]. LTA can bind CD14 and
then stimulates TLR activation [16,29]. After LTA associ-
ates with TLR2, NF-κB can be activated by protein
kinases and is then translocated to nuclei from the cyto-
plasm [11]. NF-κB regulates certain gene expressions to
AB
1 2 3 4





























Figure 6 Effects of lipoteichoic acid (LTA) on the
phosphorylation of mitogen-activated/extracellular signal-
regulated kinase kinase (MEK)1. A549 cells were exposed to 30
μg/ml LTA for 1, 6, and 24 h. Phosphorylated MEK1 (p-MEK1) was
immunodetected (A, top panel). ERK2 was detected as the internal
standard (bottom panel). These immunorelated protein bands were
quantified and analyzed (B). Each value represents the mean ± SEM
for n = 6. An asterisk (*) indicates that a value significantly differed
from the control group, p < 0.05. AU, arbitrary unit.
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[30,31]. A previous study showed that LTA induced
cyclooxygenase-2 expression in epithelial cells via IκB
degradation and successive p65 NF-κB translocation
[32]. LTA could induce SP-A mRNA expression in A549
cells. Our bioinformatic search revealed that NF-κB-
DNA-binding motifs were found in the promoter
regions of the sp-a gene. Suppressing NF-κB activation
using BAY 11–7082 simultaneously inhibited LTA-
induced SP-A mRNA expression. Thus, LTA transcrip-
tionally induces SP-A expression through inducing NF-κB
expression and translocation.
Our present results revealed that the phosphoryla-
tion of ERK1/2 was associated with NF-κB activation.
Sequentially, ERK1/2-activated IκBα kinase can phos-
phorylate IκB at two conserved serine residues in the N-
terminus, triggering the degradation of this inhibitor and
allowing for the rapid translocation of NF-κB into nuclei
[16,20]. Accordingly, LTA-induced activation of A549
cells is mainly due to the improvement in ERK1/2 phos-
phorylation. Roles of ERK1 and ERK2 in LTA-induced
SP-A expression were not determined in this study but
will be validated using RNA interference in our next
study. There is growing evidence that the ERK signalingpathway, which contributes to regulating inflammatory
events [33]. Therefore, LTA regulates SP-A expression in
alveolar type II epithelial cells in the course of eliciting
ERK1/2 phosphorylation and subsequent activation of
the transcription factor, NF-κB.
ERK activation is mediated by at least three different
pathways: a Raf/MEK-dependent pathway, a PI3K/Raf-
independent pathway that strongly activates MEK, and a
third undetermined pathway that directly activates ERK
proteins [34]. This study showed that LTA time-
dependently increased levels of phosphorylated MEK1.
Thus, one of the possible reasons explaining why LTA
stimulates ERK1/2 activation is the increase in MEK1
phosphorylation. MAPK-regulating signals place this
family of protein kinases in an apparently linear signal-
ing cascade downstream of growth factor receptors,
adaptor proteins, guanine-nucleotide exchange factors,
Ras, Raf, and MEK [19]. The present study demonstrates
that LTA can induce SP-A expression via MEK-
dependent activation of the protein kinase ERK1/2-sig-
naling pathway.Conclusions
In summary, we used an alveolar epithelial cell model to
study the immunomodulatory responses of LTA. Our
results revealed that LTA can induce inflammatory
responses in alveolar epithelial A549 cells by means of
enhancing SP-A mRNA and protein syntheses. More-
over, the signal-transducing mechanisms of LTA-caused
regulation of SP-A expression arise through the cascade
phosphorylations of MEK1 and ERK1/2. In succession,
LTA increased NF-κB expression and translocation.
LTA-induced SP-A production in alveolar type II epithe-
lial cells may indicate the status of gram-positive bac-
teria-caused septic shock and acute lung injury. More
molecular pathways should be investigated and proven
in the future. However, there are certain limitations of
this study, including the use of A549 cells, which are
derived from human lung carcinoma. The effects of LTA
on A549 cells may differ from those on normal alveolar
epithelial cells. Thus, we will perform a translational
study to evaluate the effects of LTA on alveolar epithelial
cells of animals with acute lung injury.Abbreviations
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